Potent and selective HIV-1 ribonuclease H inhibitors based on a 1-hydroxy-1,8-naphthyridin-2(1H)-one scaffold by Williams, Peter D., Staas, Donnette D., Venkatraman, Shankar, Loughran, H. Marie, Ruzek, Rowena D., Booth, Theresa M., Lyle, Terry A., Wai, John S., Vacca, Joseph P., Feuston, Bradley P., Ecto, Linda T., Flynn, Jessica A., DiStefano, Daniel J., Hazuda, Daria J., Bahnck, Carolyn M., Himmelberger, Amy L., Dornadula, Geetha, Hrin, Renee C., Stillmock, Kara A., Witmer, Marc V., Miller, Michael D., Grobler, Jay A.

Get full text

Disubstituted pyrimidines as Lck inhibitors by Hunt, Julianne A., Beresis, Richard T., Goulet, Joung L., Holmes, Mark A., Hong, Xinfang J., Kovacs, Ernest, Mills, Sander G., Ruzek, Rowena D., Wong, Frederick, Hermes, Jeffrey D., Park, Young-Whan, Salowe, Scott P., Sonatore, Lisa M., Wu, Lin, Woods, Andrea, Zaller, Dennis M., Sinclair, Peter J.

Get full text

p38 Inhibitors: piperidine- and 4-aminopiperidine-substituted naphthyridinones, quinolinones, and dihydroquinazolinones by Hunt, Julianne A, Kallashi, Florida, Ruzek, Rowena D, Sinclair, Peter J, Ita, Ida, McCormick, Sherrie X, Pivnichny, James V, Hop, C.E.C.A, Kumar, Sanjeev, Wang, Zhen, O'Keefe, Stephen J, O'Neill, Edward A, Porter, Gene, Thompson, James E, Woods, Andrea, Zaller, Dennis M, Doherty, James B

Get full text

p38 MAP kinase inhibitors: Metabolically stabilized piperidine-substituted quinolinones and naphthyridinones by Bao, Jianming, Hunt, Julianne A., Miao, Shouwu, Rupprecht, Kathleen M., Stelmach, John E., Liu, Luping, Ruzek, Rowena D., Sinclair, Peter J., Pivnichny, James V., Hop, Cornelis E.C.A., Kumar, Sanjeev, Zaller, Dennis M., Shoop, Wesley L., O’Neill, Edward A., O’Keefe, Stephen J., Thompson, Chris M., Cubbon, Rose M., Wang, Ruixiu, Zhang, Wen Xiao, Thompson, James E., Doherty, James B.

Get full text